Insufficient scRNA-seq data for expression of HORMAD2 at single-cell level.
Insufficient scRNA-seq data for expression of HORMAD2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 89% | 61.42 | 201 / 226 | 30% | 1.05 | 123 / 406 |
brain | 91% | 15.42 | 2400 / 2642 | 7% | 0.12 | 50 / 705 |
kidney | 63% | 4.34 | 56 / 89 | 3% | 0.06 | 30 / 901 |
adipose | 42% | 3.30 | 507 / 1204 | 0% | 0 | 0 / 0 |
breast | 37% | 3.79 | 171 / 459 | 0% | 0.01 | 4 / 1118 |
lung | 27% | 1.48 | 155 / 578 | 3% | 0.06 | 40 / 1155 |
spleen | 27% | 1.55 | 66 / 241 | 0% | 0 | 0 / 0 |
thymus | 15% | 1.04 | 97 / 653 | 0% | 0 | 0 / 605 |
skin | 13% | 0.68 | 233 / 1809 | 0% | 0.02 | 2 / 472 |
stomach | 11% | 0.49 | 40 / 359 | 2% | 0.05 | 6 / 286 |
intestine | 12% | 0.55 | 114 / 966 | 0% | 0.00 | 1 / 527 |
prostate | 12% | 1.86 | 29 / 245 | 0% | 0 | 0 / 502 |
peripheral blood | 11% | 0.55 | 100 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 8% | 0.38 | 106 / 1335 | 0% | 0 | 0 / 0 |
adrenal gland | 8% | 0.40 | 20 / 258 | 0% | 0 | 0 / 230 |
esophagus | 6% | 0.49 | 93 / 1445 | 1% | 0.04 | 2 / 183 |
uterus | 6% | 0.33 | 11 / 170 | 0% | 0.01 | 2 / 459 |
bladder | 5% | 0.19 | 1 / 21 | 0% | 0.01 | 2 / 504 |
ovary | 5% | 0.24 | 9 / 180 | 0% | 0 | 0 / 430 |
heart | 5% | 0.21 | 40 / 861 | 0% | 0 | 0 / 0 |
muscle | 4% | 0.32 | 36 / 803 | 0% | 0 | 0 / 0 |
pancreas | 3% | 0.13 | 9 / 328 | 1% | 0.01 | 1 / 178 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0051321 | Biological process | meiotic cell cycle |
GO_0051177 | Biological process | meiotic sister chromatid cohesion |
GO_0005813 | Cellular component | centrosome |
GO_0005694 | Cellular component | chromosome |
GO_0000795 | Cellular component | synaptonemal complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
Gene name | HORMAD2 |
Protein name | HORMA domain containing 2 HORMA domain-containing protein 2 |
Synonyms | |
Description | FUNCTION: Essential for synapsis surveillance during meiotic prophase via the recruitment of ATR activity. Plays a key role in the male mid-pachytene checkpoint and the female meiotic prophase checkpoint: required for efficient build-up of ATR activity on unsynapsed chromosome regions, a process believed to form the basis of meiotic silencing of unsynapsed chromatin (MSUC) and meiotic prophase quality control in both sexes. Required for the DNA double-strand break-independent, BRCA1-dependent activation of ATR on the sex chromosomes that is essential for normal sex body formation (By similarity). . |
Accessions | F8WES9 ENST00000336726.11 ENST00000450612.5 ENST00000403975.1 Q8N7B1 |